Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Plague emerged earlier than thought and hit hunter-gatherers hard

21

Jun 2026

Plague emerged earlier than thought and hit hunter-gatherers hard

Ancient DNA from 46 Lake Baikal hunter-gatherers revealed two early plague outbreak phases about 5,500 years ago, with Yersinia pestis detected in 18 individuals. The findings suggest these basal plague strains caused lethal, child-heavy outbreaks long before dense farming societies, cities, or classical flea-borne bubonic plague emerged.

Autonomous medical AI outperforms doctors in simulated EHR cases

21

Jun 2026

Autonomous medical AI outperforms doctors in simulated EHR cases

MIRA, an autonomous AI agent tested in a sandboxed electronic health record, diagnosed 574 real emergency department cases with 88.9% accuracy and outperformed physicians in a matched 311-case comparison. The system ordered tests, generated medication plans, and made admission decisions in simulation, but the authors stress that prospective validation, governance, and physician oversight are still essential.

Bogotá’s strictest COVID restrictions delivered the clearest air-quality gains

21

Jun 2026

Bogotá’s strictest COVID restrictions delivered the clearest air-quality gains

A natural quasi-experiment in Suba, Bogotá, found that more stringent COVID-19 mobility restrictions were associated with larger reductions in PM₁₀ and PM₂.₅ air pollution. The findings suggest targeted traffic and emissions controls could improve urban air quality, although ozone responses were more complex, and the results may not generalize beyond this high-traffic district.

Google’s AMIE beats doctors on key simulated disease-management tasks

21

Jun 2026

Google’s AMIE beats doctors on key simulated disease-management tasks

Google’s AMIE research AI matched primary care physicians overall in simulated, multi-visit disease-management reasoning and scored higher on several measures of plan appropriateness, treatment precision, investigation precision, and guideline alignment. The study highlights the promise of conversational AI for longitudinal care, while emphasizing that AMIE is not ready for clinical use and still needs prospective real-world testing.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.